We are live on
!
Find out more
FA
FDx Advisors Portfolio holdings
AUM
$313M
1-Year Est. Return
18.92%
This Fund
S&P 500
This Quarter
Est. Return
+1.2%
1 Year Est. Return
+18.92%
3 Year Est. Return
+56.32%
5 Year Est. Return
+58.97%
10 Year Est. Return
+208.95%
AUM
$1.2B
AUM Growth
+$195M
(+19%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
25.58%
Holding
818
New
169
Increased
465
Reduced
116
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$18.3M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$12.1M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$8.51M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.64M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$5.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$22.7M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$14M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$11M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$10.4M |
| 5 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$4.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.08% |
| 2 | Technology | 7.31% |
| 3 | Healthcare | 7.08% |
| 4 | Consumer Discretionary | 5.63% |
| 5 | Industrials | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCR
201
DELISTED
OMNICARE INC
OCR
| $1.07M | 0.09% |
17,944
-1,671
| -9% | -$101K |
|
|
QCOR
202
DELISTED
QUESTCOR PHARMA INC
QCOR
| $1.07M | 0.09% |
16,428
+5,823
| +55% | +$372K |
|
|
MON
203
DELISTED
Monsanto Co
MON
| $1.06M | 0.09% |
9,288
+513
| +6% | +$57.1K |
|
|
FITB
204
Fifth Third Bancorp
FITB
$52B
| $1.05M | 0.09% |
45,955
+28,277
| +160% | +$616K |
|
205
Jack Henry & Associates
JKHY
$10.7B
| $1.05M | 0.09% |
18,892
-4,021
| -18% | -$231K |
|
206
Xerox
XRX
$337M
| $1.05M | 0.09% |
35,318
+10,802
| +44% | +$316K |
|
207
Nu Skin
NUS
$247M
| $1.05M | 0.09% |
12,685
+7,755
| +157% | +$681K |
|
|
ENH
208
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.05M | 0.09% |
19,460
+6,112
| +46% | +$325K |
|
209
Kimberly-Clark
KMB
$36.4B
| $1.04M | 0.09% |
9,883
+1,218
| +14% | +$126K |
|
|
RDS.A
210
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.04M | 0.09% |
14,291
+7,428
| +108% | +$531K |
|
211
Ameriprise Financial
AMP
$46.8B
| $1.04M | 0.09% |
9,440
+3,627
| +62% | +$397K |
|
212
Fossil Group
FOSL
$239M
| $1.04M | 0.09% |
8,896
+3,856
| +77% | +$449K |
|
213
Grand Canyon Education
LOPE
$3.71B
| $1.04M | 0.09% |
22,187
+6,634
| +43% | +$307K |
|
|
AHL
214
DELISTED
ASPEN Insurance Holding Limited
AHL
| $1.04M | 0.09% |
26,095
+8,207
| +46% | +$319K |
|
|
IPG
215
DELISTED
Interpublic Group of Companies
IPG
| $1.03M | 0.09% |
60,176
+18,863
| +46% | +$322K |
|
216
Kohl's
KSS
$2.03B
| $1.03M | 0.09% |
18,122
+9,287
| +105% | +$498K |
|
217
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.03M | 0.09% |
8,020
-33
| -0.4% | -$4.23K |
|
218
Duke Energy
DUK
$102B
| $1.03M | 0.09% |
14,421
+2,294
| +19% | +$160K |
|
|
TRW
219
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $1.02M | 0.09% |
12,503
+6,751
| +117% | +$524K |
|
220
iShares Select Dividend ETF
DVY
$24B
| $1.01M | 0.08% |
13,816
+230
| +2% | +$16.3K |
|
221
McDonald's
MCD
$188B
| $1.01M | 0.08% |
10,261
+1,261
| +14% | +$121K |
|
222
Vanguard Mid-Cap ETF
VO
$106B
| $1.01M | 0.08% |
35,420
+19,292
| +120% | +$535K |
|
223
Capital One
COF
$124B
| $1M | 0.08% |
12,962
+8,806
| +212% | +$646K |
|
|
PXD
224
DELISTED
Pioneer Natural Resource Co.
PXD
| $994K | 0.08% |
5,309
+103
| +2% | +$18.8K |
|
225
iShares US Technology ETF
IYW
$23.7B
| $986K | 0.08% |
43,304
+21,972
| +103% | +$490K |
|
Similar funds
WMIG
JIC
PAM
KA
MIM
SL
TF
CFLC
FDx Advisors's Q1 2014 Portfolio in Review
As of Q1 2014, FDx Advisors held 818 positions worth $1.2B, up 19% from $1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
FDx Advisors deployed $161M of net new capital in Q1 2014, opening 169 new positions and adding to 465 existing holdings. Its largest new stake was Eli Lilly: 43,355 shares worth $2.55M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.5% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Novo Nordisk, an estimated $22.7M trimmed.
- FDx Advisors's largest Q1 2014 buy was Eli Lilly: 43,355 shares worth $2.55M.
- FDx Advisors added most to iShares S&P 500 Growth ETF in Q1 2014, an estimated $18.3M increase.
- FDx Advisors's biggest Q1 2014 reduction was Novo Nordisk, cutting an estimated $22.7M.
- FDx Advisors fully exited WisdomTree Japan Hedged Equity Fund in Q1 2014, selling an estimated $14M.
- FDx Advisors's ten largest holdings make up 26% of its $1.2B portfolio in Q1 2014.
- FDx Advisors opened 169 new positions and closed 56 in Q1 2014.
- FDx Advisors's portfolio value rose 19% quarter-over-quarter to $1.2B.
Based on FDx Advisors's 13F filing for Q1 2014, filed 15 May 2014.